The Frequency of Hydronephrosis at Initial Diagnosis and its Effect on Recurrence and Progression in Patients With Superficial Bladder Cancer

Journal of Urology

Volumn 178, Issue 3, 2007, Pages 802-806

  Divrik, Rauf Taner ^a   Şahin, Ali ^a   Altok, Muammer ^a   Ünlü, Nuri ^a   Zorlu, Ferruh ^a  

^a TEPECIK EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

bladder; bladder neoplasms; carcinoma; hydronephrosis; prognosis; transitional cell

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HYDRONEPHROSIS; INTRAVENOUS PYELOGRAPHY; INTRAVENOUS UROGRAPHY; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; TRANSITIONAL CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYDRONEPHROSIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; URINARY BLADDER NEOPLASMS;

EID: 34547658923     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.05.054     Document Type: Article

References (20)

1. Sylvester R.J., Van der Meijden A.P.M., Oosterlinck W., Witjes J.A., Bouffioux C., Denis L., et al. Predicting recurrence and progression in individual patients with stage TaT1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49 (2006) 466
2. Kiemeney L.A., Witjes J.A., Heijbroek R.P., Koper N.P., Verbeek A.L., Debruyne F.M., and Members of the Dutch South-East Co-operative Urological Group. Should random urothelial biopsies be taken from patients with primary superficial bladder cancer?. A decision analysis. Br J Urol 73 (1994) 164
3. Millan-Rodriguez F., Chechile-Toniolo G., Salvador-Bayarri J., Palou J., and Vicente-Rodriguez J. Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol 163 (2000) 73
4. Hisataki T., Miyao N., Masumori N., Takahashi A., Yanase M., Itoh N., et al. Risk factors for multiple intravesical recurrences of superficial bladder cancer. Urology 58 (2001) 935
5. Herr H.W. Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy. J Urol 174 (2005) 2134
6. Divrik R.T., Yildirim Ü., Zorlu F., and Özen H. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial. J Urol 175 (2006) 1641
7. Reading J., Hall R.R., and Palmar M.K. The application of a prognostic factor analysis for Ta.T1 bladder cancer in routine urological practice. Br J Urol 75 (1995) 604
8. Solsona E., Iborra I., Dumont R., Rubio-Briones J., Casanova J., and Almenar S. The 3-month clinical response to intravesical therapy as a predictive factor for progression in patients with high risk superficial bladder cancer. J Urol 164 (2000) 685
9. Orsola A., Trias I., Raventos C.X., Espanol I., Cecchini L., Bucar S., et al. Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG treated and BCG non-treated patients. Eur Urol 48 (2005) 231
10. Bernardini S., Billerey C., Martin M., Adessi G.L., Wallerand H., and Bittard H. The predictive value of muscularis mucosae invasion and p53 over expression on progression of stage T1 bladder carcinoma. J Urol 165 (2001) 42
11. Fujii Y., Fukui I., Kihara K., Tsujii T., Ischizaka K., Kageyama Y., et al. Significance of bladder neck involvement on progression in superficial bladder cancer. Eur Urol 33 (1998) 464
12. Kurth K.H., Denis L., Bouffioux C., Sylvester R., Debruyne F.M.J., Pavone-Macaluso M., et al. Factors affecting recurrence and progression in superficial bladder tumors. Eur J Cancer 31A (1995) 1840
13. Lee C.T., Montie J.E., Zhang Y.X., Dunn R.L., and Wood D.P. Lymphovascular invasion is an independent predictor of survival in cT1 bladder cancer. J Urol 173 (2005) 246. abstract 911
14. Kamat A.M., Gee J.R., Dinney C.P.N., Grossman H.B., Swanson D.A., Millikan R.E., et al. The case for early cystectomy in non muscle-invasive micropapillary transitional cell carcinoma of the bladder. J Urol 173 (2005) 247. abstract 91
15. Sylvester R.J., Van der Meijden A.P., and Lamm D.L. Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J Urol 168 (2002) 1964
16. Allard P., Bernard P., Fradet Y., and Tetu B. The early clinical course of primary Ta and T1 bladder cancer: a proposed prognostic index. Br J Urol 81 (1998) 692
17. Lieskovsky G., Ahlering T., and Skinner D.G. Diagnosis and staging of bladder cancer. In: Skinner D.G., and Lieskovsky G. (Eds). Diagnosis and Management of Genitourinary Cancer (1988), WB Saunders Co, Philadelphia 264 chapt 14
18. Haleblian G.E., Skinner E.C., Dickinson M.G., Lieskovsky G., Boyd S.T., and Skinner D.G. Hydronephrosis as a prognostic indicator in bladder cancer patients. J Urol 160 (1998) 2011
19. Leibovitch I., Ben-Chaim J., Ramon J., Madjar I., Engelberg I.S., and Goldwasser B. The significance of ureteral obstruction in invasive transitional cell carcinoma of the urinary bladder. J Surg Oncol 52 (1993) 31
20. Hardeman S.W., and Soloway M.S. Urethral recurrence following radical cystectomy. J Urol 144 (1990) 666